<DOC>
	<DOC>NCT02062034</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of ubiquinone and combined antioxidant therapy on progression, clinical regression, oxidative stress markers and mitochondrial dysfunction in non-proliferative diabetic retinopathy.</brief_summary>
	<brief_title>Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy</brief_title>
	<detailed_description>The investigators are interested in demonstrating the efficacy of Ubiquinone and combined antioxidant therapy in the pharmacological management of diabetic retinopathy since early stages.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Copper</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Patients with type 2 diabetes mellitus Patients with non proliferative diabetic retinopathy Glycated hemoglobin &lt; 12.0% Signing of informed consent Patients with clinically significant macular edema Patients with diabetic retinopathy advanced lesions that have required or require specific treatment (laser, vitrectomy) Pretreatment with argon laser or excimer laser Ophthalmology surgery Any other associated ocular pathology (glaucoma, cataracts, changing cornea dystrophy, macular degeneration) Pregnancy, lactation, inadequate use of contraception Antioxidant drug and/or supplements six months previous to enrollment Renal and/or hepatic failure Age under 30 or over 75 years Severe cardiovascular disease (myocardial infarction, stroke, severe peripheral vasculopathy) Blood dyscrasias Have or have had cancer or other serious illness Neurodegenerative process Allergy to vitamins</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Oxidative stress</keyword>
	<keyword>Mitochondrial dysfunction</keyword>
	<keyword>Ubiquinone</keyword>
	<keyword>Antioxidant combined therapy</keyword>
	<keyword>Diabetic retinopathy</keyword>
</DOC>